Articles


Johnson & Johnson

Johnson & Johnson Advances Ulcerative Colitis Treatment with FDA Filing for TREMFYA® Subcutaneous Regimen

SPRING HOUSE, PA – Johnson & Johnson (NYSE: JNJ) has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval for a subcutaneous (SC) …

Johnson & Johnson Advances Ulcerative Colitis Treatment with FDA Filing for TREMFYA® Subcutaneous Regimen Read More
CCEDC Stakeholders Meeting 2024

Christmas Concert

Experience the Magic: Immaculata Symphony’s Dazzling Christmas Concert Unveils Holiday Wonders!

IMMACULATA, PA – Immerse yourself in the spirit of the season as the Immaculata Symphony presents its annual Christmas concert, “A Classic Christmas,” on Sunday, December 8, 2024. This festive performance, …

Experience the Magic: Immaculata Symphony’s Dazzling Christmas Concert Unveils Holiday Wonders! Read More